Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists

JAMA. 2024 Jul 2;332(1):16-18. doi: 10.1001/jama.2024.7062.

Authors

Jamy D Ard¹, Kristina H Lewis¹, Justin B Moore^{1

2}

Affiliations

¹ Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
² Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

PMID: 38744427
DOI: 10.1001/jama.2024.7062

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Exercise
Glucagon-Like Peptide-1 Receptor / agonists
Glucagon-Like Peptide-1 Receptor Agonists* / therapeutic use
Healthy Lifestyle
Humans
Hypoglycemic Agents* / therapeutic use
Life Style*
Obesity* / drug therapy
Obesity* / therapy
Weight Loss

Substances

Glucagon-Like Peptide-1 Receptor
Glucagon-Like Peptide-1 Receptor Agonists
Hypoglycemic Agents